New insights into the role of STAT3 in IBD

  • Li Y
  • De Haar C
  • Peppelenbosch M
 et al. 
  • 23


    Mendeley users who have this article in their library.
  • 17


    Citations of this article.


Although it is clear that inflammatory bowel disease (IBD) involves an inappropriate immune response to floral components, the molecular determinants that mediate the gene transcription underlying and aggravating disease remain poorly understood. There is building momentum, however, that implicates differential regulation of the signal transducer and activator of transcription (STAT) 3 as an important factor in mediating pathogenic gene transcription in IBD, and this notion was reinforced by studies presented at the recent 2011 Digestive Disease Week (DDW) conference in Chicago. In the present report we integrate the existing body of literature with the novel data presented at this meeting to present a kaleidoscopic scheme so as to provide further insight into the role of STAT3 in IBD. A genetic propensity to its overactivation in the monocyte and epithelial compartment compromises the innate defense to allow low-level bacterial infection to fester and eventually initiate disease. The subsequent STAT3 activation in various relevant mucosal immune compartments, in particular epithelial cell proliferation and survival, and the function of the regulatory T cells and Th17 cells allow the mucosal immune system to fight the infection and return to steady state. As such, the action of STAT3 in IBD is highly context-dependent but always important.

Author-supplied keywords

  • IBD
  • IEC
  • STAT3
  • Th17

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text


  • Yi Li

  • Colin De Haar

  • Maikel P. Peppelenbosch

  • C. Janneke Van Der Woude

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free